The Bio Report

563 Episoder

1. Improving Healthcare by Addressing the Most Challenging Patients

   Udgivet: 4.8.2016
2. The Case for Chasing Unpopular Indications

   Udgivet: 28.7.2016
3. Improving Drug Development through Better Use of Biomarkers

   Udgivet: 21.7.2016
4. Measuring the Value of Incubators and Accelerators

   Udgivet: 14.7.2016
5. Enlisting New and Old Tools to Combat Antibiotic Resistance

   Udgivet: 7.7.2016
6. Advancing Cancer Care with New Diagnostic Tools

   Udgivet: 30.6.2016
7. A Biotech Reinvents Itself and How to Price Drugs

   Udgivet: 23.6.2016
8. Using Technology to Modernize Preclinical Development

   Udgivet: 16.6.2016
9. Can the Biotech Industry Stay on Track through Innovative Pricing

   Udgivet: 8.6.2016
10. Wall Street Turns Its Eyes to ASCO

    Udgivet: 2.6.2016
11. Understanding the Disease It Never Was on House

    Udgivet: 26.5.2016
12. Why the State of Innovation Is Encouraging

    Udgivet: 19.5.2016
13. Can Market Forces Fix Drug Pricing

    Udgivet: 12.5.2016
14. Digital Health Device Seeks to Push Beyond Cannabis to Test Food, Air, and Water

    Udgivet: 5.5.2016
15. Why the Cancer Moonshot Offers a Chance to Rethink Funding Priorities

    Udgivet: 28.4.2016
16. Medtronic Advances Toward an Artificial Pancreas

    Udgivet: 21.4.2016
17. Using Real-Time Data to Detect HIV Outbreaks

    Udgivet: 14.4.2016
18. Why Pharma Needs to Forge New Drug Pricing Models

    Udgivet: 7.4.2016
19. Gensight Targets Gene Therapy on Diseases that Blind

    Udgivet: 31.3.2016
20. A Vial Problem: How We Waste $3 Billion of Cancer Drugs a Year

    Udgivet: 24.3.2016